Editorial Topical Sections

Dopamine and serotonin in fear extinction: some key questions to be addressed

  • Citation: Carmelo M Vicario, Gabriella Martino. Dopamine and serotonin in fear extinction: some key questions to be addressed[J]. AIMS Neuroscience, 2020, 7(3): 271-274. doi: 10.3934/Neuroscience.2020014

    Related Papers:

    [1] Sara Arciniegas Ruiz, Eliav Tikochinsky, Vardit Rubovitch, Chaim G Pick, Bernard Attali . Contextual fear response is modulated by M-type K+ channels and is associated with subtle structural changes of the axon initial segment in hippocampal GABAergic neurons. AIMS Neuroscience, 2023, 10(1): 33-51. doi: 10.3934/Neuroscience.2023003
    [2] I. Banegas, I. Prieto, A.B. Segarra, M. de Gasparo, M. Ramírez-Sánchez . Study of the Neuropeptide Function in Parkinson’s Disease Using the 6-Hydroxydopamine Model of Experimental Hemiparkinsonism. AIMS Neuroscience, 2017, 4(4): 223-237. doi: 10.3934/Neuroscience.2017.4.223
    [3] Sairam Ramesh, Arosh S. Perera Molligoda Arachchige . Depletion of dopamine in Parkinson's disease and relevant therapeutic options: A review of the literature. AIMS Neuroscience, 2023, 10(3): 200-231. doi: 10.3934/Neuroscience.2023017
    [4] Timothy J. Ricker . The Role of Short-term Consolidation in Memory Persistence. AIMS Neuroscience, 2015, 2(4): 259-279. doi: 10.3934/Neuroscience.2015.4.259
    [5] Masatoshi Takita, Yumi Izawa-Sugaya . Neurocircuit differences between memory traces of persistent hypoactivity and freezing following fear conditioning among the amygdala, hippocampus, and prefrontal cortex. AIMS Neuroscience, 2021, 8(2): 195-211. doi: 10.3934/Neuroscience.2021010
    [6] Anmol Kumar, Ajay Kumar Gupta, Prashant Kumar Singh . Novel perspective of therapeutic modules to overcome motor and nonmotor symptoms in Parkinson's disease. AIMS Neuroscience, 2024, 11(3): 312-340. doi: 10.3934/Neuroscience.2024020
    [7] Mani Pavuluri, Kelley Volpe, Alexander Yuen . Nucleus Accumbens and Its Role in Reward and Emotional Circuitry: A Potential Hot Mess in Substance Use and Emotional Disorders. AIMS Neuroscience, 2017, 4(1): 52-70. doi: 10.3934/Neuroscience.2017.1.52
    [8] Stefan G. Hofmann, Elizabeth A. Mundy, Joshua Curtiss . Neuroenhancement of Exposure Therapy in Anxiety Disorders. AIMS Neuroscience, 2015, 2(3): 123-138. doi: 10.3934/Neuroscience.2015.3.123
    [9] I. Banegas, I. Prieto, A.B. Segarra, M. Martínez-Cañamero, M. de Gasparo, M. Ramírez-Sánchez . Angiotensin II, dopamine and nitric oxide. An asymmetrical neurovisceral interaction between brain and plasma to regulate blood pressure. AIMS Neuroscience, 2019, 6(3): 116-127. doi: 10.3934/Neuroscience.2019.3.116
    [10] Ziphozethu Ndlazi, Oualid Abboussi, Musa Mabandla, Willie Daniels . Memantine increases NMDA receptor level in the prefrontal cortex but fails to reverse apomorphine-induced conditioned place preference in rats. AIMS Neuroscience, 2018, 5(4): 211-220. doi: 10.3934/Neuroscience.2018.4.211


  • Fear extinction learning is considered a key process for a successful treatment of anxiety disorders and the post-traumatic stress disorder (PTSD) [1], two mental health disorders that might affect several clinical conditions including diabetes [2][6], which involves the gradual reduction of the fear response when the conditioned stimulus—a neutral stimulus associated with an aversive stimulus (i.e. the unconditioned stimulus)—is repeatedly presented without the aversive outcome.

    A recent review [7] highlighted the role of the dopaminergic system in fear extinction. The involvement of dopamine, a neurobiological mediator classically associated with the experience of reward [8][10], in fear extinction [11],[12] is interpreted in line with the suggestion that the omission of an unconditioned adverse stimulus in association with a conditioned (i.e., neutral) stimulus is experienced/interpreted as appetitive event. This interpretation fits with the evidence that the experience of pain relief is associated with a release of dopamine at the ventral tegmental area (VTA) [13], similarly to what happens in response to a reward [14]. Nevertheless, it seems simplistic to talk about the role of dopamine in fear extinction without mentioning the contribution of serotonin, which is crucial in encoding aversive motivational outcomes, and represents the natural opponent of dopaminergic system in conditioning tasks [15]. First of all, evidence exists about an involvement of serotonin in extinction learning [e.g., [16] for a review].

    The scientific literature has also shown that in the context of reward and aversion processing both chemical messengers work in antagonistic way [15],[17]. This is suggested by research on Prediction Error (PE): an increase in the activity of dopaminergic system and a decrease in the activity of serotonergic system encode PE associated with undelivered punishment; furthermore, the dopaminergic system is activated when the reward is signaled, while the serotonergic system is activated when the expected reward fails to arrive [15]. This implies that an exhaustive analysis of the role of dopaminergic system in fear extinction should take into account the symmetric involvement of serotonergic system and that, because of this interdependence, it can be technically challenging to clarify whether a fear extinction learning response pattern, generated in an experimental and/or clinical setting, truly reflects the activity of the dopaminergic system, the activity of the serotonergic system, or it is the result of a synergistic interaction between these two systems.

    Worthy of mention is also the necessity to clarify whether the role played by dopaminergic and serotoninergic systems in fear extinction learning is inexorably interdependent, or it is possible to identify a degree of autonomy in each system with regard to the process of fear extinction learning. A closer look at the process of fear extinction could add some timely insights in this regard.

    When speaking about fear extinction it is important to distinguish between learning and consolidation [18]. Learning represents the first stage of memorization that takes place during wakefulness and is based on the process of encoding. The consolidation represents the next step, a fundamental process for the stabilization of new traces of memory that occurs during sleep. In line with this distinction, the current literature suggests that high activity of serotonergic system could be selectively involved in the consolidation of fear extinction material. This is corroborated by the evidence [19], in animal models (i.e., serotonin transporter knock-out mouse) that the genetically driven loss of serotonin function is associated with a selective deficit in extinction recall (i.e., 24 h later), which reflects the consolidation process. Importantly, no effect was reported in the encoding stage by the authors of this study [19]. This result is confirmed in a further investigation [20] where the stimulation or blockade of serotonin 2A receptor in mice respectively facilitates and impairs the consolidation of fear extinction memory traces with no effects on the process of encoding (see also the study of Barratta et al. [21] showing that high levels of serotonin can be essential for the consolidation phase of fear memories). In contrast with this evidence, the study by Burghardt et al. [22] has shown that chronic administration of citalopram (a serotonin reuptake inhibitor) to rats, given between fear conditioning and extinction (i.e., during the learning stage), impaired acquisition of extinction. In summary, the research discussed above suggests that high levels of serotonin can both facilitate and interfere with fear extinction, depending on which stage of memory is considered. Current evidence on dopaminergic system suggests the potential involvement of this neurotransmitter both in the encoding and the consolidation stages of the fear extinction learning process, as also reported by Kalish et al. [7] in their article [23]. Given these premises, one might speculate the existence of an interaction between dopamine and serotonin during the learning stage, as low levels of the latter monoamine might be necessary for successful fear extinction learning (this can be inferred by the evidence [22] that high levels of serotonin during the learning stage interfere with fear extinction).

    In conclusion, the current research leaves open the hypothesis that the effect of dopaminergic system on learning of fear extinction memories could reflects, at least in part, some interaction with serotonergic system. Therefore, both monoamine should be simultaneously considered when speaking about fear extinction. This is supported also at the neural level, as the serotonergic system of the dorsal raphe nucleus [24], which is considered the system that opposes dopaminergic activity [25], has important innervations with several regions of the brain considered crucial in fear extinction learning such as the VTA [26], the Amygdala [27], and the Ventromedial Prefrontal Cortex [27].



    Conflict of interest



    The authors declare that there are no conflicts of interest.

    [1] Vicario CM, Salehinejad MA, Felmingham K, et al. (2019) A systematic review on the therapeutic effectiveness of non-invasive brain stimulation for the treatment of anxiety disorders. Neurosci Biobehav Rev 96: 219-231. doi: 10.1016/j.neubiorev.2018.12.012
    [2] Martino G, Langher V, Cazzato V, et al. (2019) Editorial: Psychological factors as determinants of medical conditions. Front Psychol 10: 2502. doi: 10.3389/fpsyg.2019.02502
    [3] Martino G, Catalano A, Bellone F, et al. (2019) As time goes by: Anxiety negatively affects the perceived quality of life in patients with Type 2 diabetes of long duration. Front Psychol 10: 1779. doi: 10.3389/fpsyg.2019.01779
    [4] Martino G, Caputo A, Bellone F, et al. (2020) Going beyond the visible in type 2 diabetes mellitus: Defense mechanisms and their associations with depression and health-related quality of life. Front Psychol 11: 267. doi: 10.3389/fpsyg.2020.00267
    [5] Martino G, Bellone F, Langher V, et al. (2019) Alexithymia and psychological distress affect perceived quality of life in patients with type 2 diabetes mellitus. Mediterr J Clin Psychol 7: 1-15.
    [6] Rosa V, Tomai M, Lauriola M, et al. (2019) Body mass index, personality traits, and body image in Italian pre-adolescents: An opportunity for overweight prevention. Psihologija 52: 379-393. doi: 10.2298/PSI181121009R
    [7] Kalisch R, Gerlicher AMV, Duvarci S (2019) A dopaminergic basis for fear extinction. Trends Cogn Sci 23: 274-277. doi: 10.1016/j.tics.2019.01.013
    [8] Schultz W (2015) Neuronal reward and decision signals: From theories to data. Physiol Rev 95: 853-951. doi: 10.1152/physrev.00023.2014
    [9] Vicario CM, Gulisano M, Martino D, et al. (2016) Timing recalibration in childhood Tourette syndrome associated with persistent pimozide treatment. Neuropsychol 10: 211-222. doi: 10.1111/jnp.12064
    [10] Vicario CM, Gulisano M, Maugeri N, et al. (2020) Delay reward discounting in adolescents with Tourette's syndrome. Mov Disord (Online ahead of print).
    [11] Salinas-Hernández XI, Vogel P, Betz S, et al. (2018) Dopamine neurons drive fear extinction learning by signaling the omission of expected aversive outcomes. Elife 7: e38818. doi: 10.7554/eLife.38818
    [12] Luo R, Uematsu A, Weitemier A, et al. (2018) A dopaminergic switch for fear to safety transitions. Nat Commun 9: 2483. doi: 10.1038/s41467-018-04784-7
    [13] Porreca F, Navratilova E (2017) Reward, motivation, and emotion of pain and its relief. Pain 158: S43-S49. doi: 10.1097/j.pain.0000000000000798
    [14] Schultz W (2016) Dopamine reward prediction-error signalling: A two-component response. Nat Rev Neurosci 17: 183-195. doi: 10.1038/nrn.2015.26
    [15] Daw ND, Kakade S, Dayan P (2002) Opponent interactions between serotonin and dopamine. Neural Netw 15: 603-616. doi: 10.1016/S0893-6080(02)00052-7
    [16] Singewald N, Schmuckermair C, Whittle N, et al. (2015) Pharmacology of cognitive enhancers for exposure-based therapy of fear, anxiety and trauma-related disorders. Pharmacol Ther 149: 150-190. doi: 10.1016/j.pharmthera.2014.12.004
    [17] Vicario CM (2013) Uncovering the neurochemistry of reward and aversiveness. Front Mol Neurosci 19: 41.
    [18] Vicario CM, Nitsche MA, Felmingham K (2017) Forgetting fear associations through tES: Which memory process might be critical? Transl Psychiatry 7: e1046. doi: 10.1038/tp.2017.26
    [19] Wellman CL, Izquierdo A, Garrett JE, et al. (2007) Impaired stress-coping and fear extinction and abnormal corticolimbic morphology in serotonin transporter knock-out mice. J Neurosci 27: 684-691. doi: 10.1523/JNEUROSCI.4595-06.2007
    [20] Zhang G, Ásgeirsdóttir HN, Cohen SJ, et al. (2013) Stimulation of serotonin 2A receptors facilitates consolidation and extinction of fear memory in C57BL/6J mice. Neuropharmacology 64: 403-413. doi: 10.1016/j.neuropharm.2012.06.007
    [21] Baratta MV, Kodandaramaiah SB, Monahan PE, et al. (2016) Stress enables reinforcement-elicited serotonergic consolidation of fear memory. Biol Psychiatry 79: 814-822. doi: 10.1016/j.biopsych.2015.06.025
    [22] Burghardt NS, Sigurdsson T, Gorman JM, et al. (2013) Chronic antidepressant treatment impairs the acquisition of fear extinction. Biol Psychiatry 73: 1078-1086. doi: 10.1016/j.biopsych.2012.10.012
    [23] Whittle N, Maurer V, Murphy C, et al. (2016) Enhancing dopaminergic signaling and histone acetylation promotes long-term rescue of deficient fear extinction. Transl Psychiatry 6: e974. doi: 10.1038/tp.2016.231
    [24] Maier SF, Seligman ME (2016) Learned helplessness at fifty: Insights from neuroscience. Psychol Rev 123: 349-367. doi: 10.1037/rev0000033
    [25] Deakin JFW (1983) Roles of brain serotonergic neurons in escape, avoidance and other behaviors. J Psychopharmacol 43: 563-577.
    [26] Ishiwata T, Hasegawa H, Greenwood BN (2017) Involvement of serotonin in the ventral tegmental area in thermoregulation of freely moving rats. Neurosci Lett 653: 71-77. doi: 10.1016/j.neulet.2017.05.030
    [27] Vicario CM, Nitsche MA, Hoysted I, et al. (2020) Anodal transcranial direct current stimulation over the ventromedial prefrontal cortex enhances fear extinction in healthy humans: A single blind sham-controlled study. Brain Stimul 13: 489-491. doi: 10.1016/j.brs.2019.12.022
  • This article has been cited by:

    1. Gabriella Martino, Andrea Caputo, Carmelo M. Vicario, Antonino Catalano, Peter Schwarz, Maria C. Quattropani, The Relationship Between Alexithymia and Type 2 Diabetes: A Systematic Review, 2020, 11, 1664-1078, 10.3389/fpsyg.2020.02026
    2. Francesco Tortora, Abed L. Hadipour, Simone Battaglia, Alessandra Falzone, Alessio Avenanti, Carmelo M. Vicario, The Role of Serotonin in Fear Learning and Memory: A Systematic Review of Human Studies, 2023, 13, 2076-3425, 1197, 10.3390/brainsci13081197
  • Reader Comments
  • © 2020 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Metrics

Article views(3815) PDF downloads(214) Cited by(2)

Article outline

Other Articles By Authors

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return

Catalog